Advanced search
Publication Cover
Leukemia & Lymphoma Volume 52, 2011 - Issue 9
Submit an article Journal homepage
594
Views
36
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Maintenance rituximab following induction chemo-immunotherapy for mantle cell lymphoma: long-term follow-up of a pilot study from the Wisconsin Oncology Network

Vaishalee P. KenkreDepartment of Medicine, University of Wisconsin, Madison, WI, USA
,
Walter L. LongDepartment of Medicine, University of Wisconsin, Madison, WI, USA
,
Jens C. EickhoffDepartment of Statistics and Bioinformatics, University of Wisconsin, Madison, WI, USA
,
Jules H. BlankGreen Bay Oncology, Green Bay, WI, USA
,
Thomas A. McFarlandUW Health Hematology/Oncology, Madison, WI, USA
,
Wayne BottnerGundersen Lutheran Medical Center, LaCrosse, WI, USA
,
Hamied RezazedehAspirus Cancer Center, Wausau, WI, USA
,
Jae E. WerndliDepartment of Medicine, University of Wisconsin, Madison, WI, USA
,
Howard H. BaileyDepartment of Medicine, University of Wisconsin, Madison, WI, USA
&
Brad S. KahlDepartment of Medicine, University of Wisconsin, Madison, WI, USACorrespondence[email protected]
 show all
Pages 1675-1680 | Received 08 Feb 2011, Accepted 07 Apr 2011, Published online: 24 Aug 2011

Citations (36)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (8)

Aleš Obr, Vit Prochazka, Tomas Papajik, Pavel Klener$suffix/text()$suffix/text(), Andrea Janikova, David Salek, David Belada, Robert Pytlík, Alice Sykorova, Heidi Mocikova, Martin Simkovic, Vit Campr, Jitka Dlouha, Tomas Furst & Marek Trněný. (2019) Maintenance rituximab in newly diagnosed mantle cell lymphoma patients: a real world analysis from the Czech lymphoma study group registry†. Leukemia & Lymphoma 60:3, pages 748-755.
Read now
Justin Karlin, Travis Peck, Karyn Prenshaw, Craig A. Portell & Maria Kirzhner. (2017) Orbital mantle cell lymphoma presenting as myasthenia gravis. Orbit 36:6, pages 365-369.
Read now
Alden A. Moccia, Emanuele Zucca & Michele Ghielmini. (2017) Is there a role for a maintenance rituximab in indolent lymphoproliferative diseases other than follicular lymphoma?. Leukemia & Lymphoma 58:1, pages 30-36.
Read now
Danyu Sun & Mitchell R Smith. (2014) Bortezomib for the treatment of mantle cell lymphoma. Expert Opinion on Orphan Drugs 2:11, pages 1233-1241.
Read now
Chadi Nabhan, Nicholas J. Ollberding, Dana Villines, Brian C.-H. Chiu, Donne Bennett D. Caces, Tina V. Valdez, Michele Ghielmini, Shu-Fang Hsu Schmitz & Sonali M. Smith. (2014) A systematic review of comparative schedule-related toxicities with maintenance rituximab in follicular and mantle cell lymphomas. Leukemia & Lymphoma 55:6, pages 1288-1294.
Read now
Andre Goy. (2013) Mantle cell lymphoma: continuously improving the odds!. Expert Opinion on Orphan Drugs 1:12, pages 1001-1018.
Read now
Jack W Hsu & Nam H Dang. (2013) The role of monoclonal antibodies in the treatment of lymphomas. Expert Opinion on Biological Therapy 13:2, pages 227-239.
Read now
Peter Martin & John P. Leonard. (2011) Advancing through maintenance in mantle cell lymphoma. Leukemia & Lymphoma 52:9, pages 1617-1618.
Read now

Articles from other publishers (28)

Sergio Cortelazzo, Maurilio Ponzoni, Andrés J.M. Ferreri & Martin Dreyling. (2020) Mantle cell lymphoma. Critical Reviews in Oncology/Hematology 153, pages 103038.
Crossref
Jason T. Romancik & Jonathon B. Cohen. (2020) Management of Older Adults with Mantle Cell Lymphoma. Drugs & Aging 37:7, pages 469-481.
Crossref
Shaum M. Kabadi, Aimee Near, Keiko Wada & Chakkarin Burudpakdee. (2020) Real-World Treatment Patterns, Adverse Events, Resource Use, and Costs Among Commercially Insured, Younger Patients with Chronic Lymphocytic Leukemia in the USA: A Retrospective Cohort Study. Advances in Therapy 37:7, pages 3129-3148.
Crossref
V I Vorobyev, E G Gemdzhian, E I Dubrovin, E S Nesterova, K D Kaplanov, E M Volodicheva, V A Zherebtsova & S K Kravchenko. (2019) Risk - adapted intensive induction therapy, autologous stem cell transplantation, and rituximab maintenance allow to reach a high 7-year survival rate in patients with mantle cell lymphoma. Terapevticheskii arkhiv 91:7, pages 41-51.
Crossref
Julie E. Chang, Lakeesha L. Carmichael, KyungMann Kim, Christopher Peterson, David T. Yang, Anne M. Traynor, Jae E. Werndli, Michael S. Huie, Thomas A. McFarland, Michael Volk, Jules Blank, Natalie S. Callander, Walter L. Longo & Brad S. Kahl. (2018) VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study. Clinical Lymphoma Myeloma and Leukemia 18:1, pages e61-e67.
Crossref
Tobias Roider & Sascha Dietrich. (2017) Maintenance Rituximab after High-Dose Therapy and Autologous Stem Cell Transplantation in Mantle Cell Lymphoma. Biology of Blood and Marrow Transplantation 23:11, pages 1811-1812.
Crossref
Matthew G. Mei, Thai M. Cao, Lu Chen, Joo Y. Song, Tanya Siddiqi, Ji-Lian Cai, Leonardo T. Farol, Monzr M. Al Malki, Amandeep Salhotra, Ibrahim Aldoss, Joycelynne Palmer, Alex F. Herrera, Jasmine Zain, Leslie L. Popplewell, Robert W. Chen, Steven T. Rosen, Stephen J. Forman, Larry Kwak, Auayporn P. Nademanee & Lihua E. Budde. (2017) Long-Term Results of High-Dose Therapy and Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: Effectiveness of Maintenance Rituximab. Biology of Blood and Marrow Transplantation 23:11, pages 1861-1869.
Crossref
Sai Ravi Pingali & Timothy S. Fenske. 2017. Hematopoietic Cell Transplants. Hematopoietic Cell Transplants 402 416 .
. 2017. Hematopoietic Cell Transplants. Hematopoietic Cell Transplants 361 444 .
Jonathon B. CohenJasmine M. ZainBrad S. Kahl. (2017) Current Approaches to Mantle Cell Lymphoma: Diagnosis, Prognosis, and Therapies. American Society of Clinical Oncology Educational Book:37, pages 512-525.
Crossref
Erden Atilla, Pinar Ataca Atilla & Taner Demirer. (2016) Current treatment strategies in relapsed/refractory mantle cell lymphoma: where are we now?. International Journal of Hematology 105:3, pages 257-264.
Crossref
Elizabeth Budde. 2017. Management of Lymphomas: A Case-Based Approach. Management of Lymphomas: A Case-Based Approach 113 122 .
Mohamed A Kharfan-Dabaja, Tea Reljic, Jessica El-Asmar, Taiga Nishihori, Ernesto Ayala, Mehdi Hamadani & Ambuj Kumar. (2016) Reduced-intensity or myeloablative allogeneic hematopoietic cell transplantation for mantle cell lymphoma: a systematic review. Future Oncology 12:22, pages 2631-2642.
Crossref
Timothy S. Fenske, Mehdi Hamadani, Jonathon B. Cohen, Luciano J. Costa, Brad S. Kahl, Andrew M. Evens, Paul A. Hamlin, Hillard M. Lazarus, Effie Petersdorf & Christopher Bredeson. (2016) Allogeneic Hematopoietic Cell Transplantation as Curative Therapy for Patients with Non-Hodgkin Lymphoma: Increasingly Successful Application to Older Patients. Biology of Blood and Marrow Transplantation 22:9, pages 1543-1551.
Crossref
Jennifer E. Vaughn, Mohamed L. Sorror, Barry E. Storer, Thomas R. Chauncey, Michael A. Pulsipher, Richard T. Maziarz, Michael B. Maris, Parameswaran Hari, Ginna G. Laport, Georg N. Franke, Edward D. Agura, Amelia A. Langston, Andrew R. Rezvani, Rainer Storb, Brenda M. Sandmaier & David G. Maloney. (2015) Long-term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Cancer 121:20, pages 3709-3716.
Crossref
Babak Rajabi & John W. Sweetenham. (2014) Mantle cell lymphoma: observation to transplantation. Therapeutic Advances in Hematology 6:1, pages 37-48.
Crossref
S Robinson, P Dreger, D Caballero, P Corradini, C Geisler, M Ghielmini, S Le Gouill, E Kimby, S Rule, U Vitolo, M Dreyling & O Hermine. (2014) The EBMT/EMCL consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphoma. Leukemia 29:2, pages 464-473.
Crossref
M Dreyling, S Ferrero & O Hermine. (2014) How to manage mantle cell lymphoma. Leukemia 28:11, pages 2117-2130.
Crossref
Julie E. ChangHailun LiMitchell R. SmithRandy D. GascoyneElisabeth M. PaiettaDavid T. YangRanjana H. Advani, Sandra J. Horning & Brad S. Kahl. (2014) Phase 2 study of VcR-CVAD with maintenance rituximab for untreated mantle cell lymphoma: an Eastern Cooperative Oncology Group study (E1405). Blood 123:11, pages 1665-1673.
Crossref
Michael E. Williams. (2013) Transplantation for mantle cell lymphoma: is it the right thing to do?. Hematology 2013:1, pages 568-574.
Crossref
Andrew M. EvensRanjana AdvaniOliver W. PressIzidore S. LossosJulie M. VoseFrancisco J. Hernandez-IlizaliturriBarrett K. RobinsonStavroula OtisLiat Nadav DaganRamsey AbdallahAimee Kroll-DesrosiersJessica L. YarberJose SandovalKelley FoyilLinda M. ParkerLeo I. GordonKristie A. BlumChristopher R. FlowersJohn P. LeonardThomas M. HabermannNancy L. Bartlett. (2013) Lymphoma Occurring During Pregnancy: Antenatal Therapy, Complications, and Maternal Survival in a Multicenter Analysis. Journal of Clinical Oncology 31:32, pages 4132-4139.
Crossref
Carla Casulo, Jocelyn Maragulia & Andrew D. Zelenetz. (2013) Incidence of Hypogammaglobulinemia in Patients Receiving Rituximab and the Use of Intravenous Immunoglobulin for Recurrent Infections. Clinical Lymphoma Myeloma and Leukemia 13:2, pages 106-111.
Crossref
Mehdi Hamadani, Wael Saber, Kwang Woo Ahn, Jeanette Carreras, Mitchell S. Cairo, Timothy S. Fenske, Robert Peter Gale, John Gibson, Gregory A. Hale, Parameswaran N. Hari, Jack W. Hsu, David J. Inwards, Rammurti T. Kamble, Anderas Klein, Dipnarine Maharaj, David I. Marks, David A. Rizzieri, Bipin N. Savani, Harry C. Schouten, Edmund K. Waller, Baldeep Wirk & Hillard M. Lazarus. (2013) Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-Unresponsive Mantle Cell Lymphoma: A Cohort Analysis from the Center for International Blood and Marrow Transplant Research. Biology of Blood and Marrow Transplantation 19:4, pages 625-631.
Crossref
Bijal D. Shah, Peter MartinEduardo M. Sotomayor. (2012) Mantle Cell Lymphoma: A Clinically Heterogeneous Disease in Need of Tailored Approaches. Cancer Control 19:3, pages 227-235.
Crossref
Peter Martin, Mitchell Smith & Brian Till. (2012) Management of mantle cell lymphoma in the elderly. Best Practice & Research Clinical Haematology 25:2, pages 221-231.
Crossref
Nishitha Reddy, John P. Greer, Stacey Goodman, Adetola Kassim, David S. Morgan, Wichai Chinratanalab, Stephen Brandt, Brian Englehardt, Olalekan Oluwole, Madan H. Jagasia & Bipin N. Savani. (2012) Consolidative therapy with stem cell transplantation improves survival of patients with mantle cell lymphoma after any induction regimen. Experimental Hematology 40:5, pages 359-366.
Crossref
Nihal E. Abdulla, Mary J. Ninan & Avi B. Markowitz. (2012) Rituximab. BioDrugs 26:2, pages 71-82.
Crossref
Marco Gunnellini & Lorenzo Falchi. (2012) Therapeutic Activity of Lenalidomide in Mantle Cell Lymphoma and Indolent Non-Hodgkin’s Lymphomas. Advances in Hematology 2012, pages 1-7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.